"Angiotensins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Oligopeptides which are important in the regulation of blood pressure (VASOCONSTRICTION) and fluid homeostasis via the RENIN-ANGIOTENSIN SYSTEM. These include angiotensins derived naturally from precursor ANGIOTENSINOGEN, and those synthesized.
| Descriptor ID |
D000809
|
| MeSH Number(s) |
D06.472.699.094 D12.644.400.070 D12.644.456.073 D12.644.548.058 D12.776.631.650.070 D23.469.050.050
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Angiotensins".
Below are MeSH descriptors whose meaning is more specific than "Angiotensins".
This graph shows the total number of publications written about "Angiotensins" by people in this website by year, and whether "Angiotensins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 0 | 1 | 1 |
| 2018 | 2 | 3 | 5 |
| 2019 | 0 | 1 | 1 |
| 2020 | 5 | 15 | 20 |
| 2021 | 0 | 5 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Angiotensins" by people in Profiles.
-
Angiotensin-converting enzyme 2: a key enzyme in key organs. J Cardiovasc Med (Hagerstown). 2022 01 01; 23(1):1-11.
-
Soluble Neuropilin-1 Response to Hypoglycemia in Type 2 Diabetes: Increased Risk or Protection in SARS-CoV-2 Infection? Front Endocrinol (Lausanne). 2021; 12:665134.
-
Dysregulation of the Renin-Angiotensin-Aldosterone System (RAA) in Patients Infected with SARS-CoV-2-Possible Clinical Consequences. Int J Mol Sci. 2021 Apr 26; 22(9).
-
Atrial appendage angiotensin-converting enzyme-2, aging and cardiac surgical patients: a platform for understanding aging-related coronavirus disease-2019 vulnerabilities. Curr Opin Anaesthesiol. 2021 Apr 01; 34(2):187-198.
-
Commentary to Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update. High Blood Press Cardiovasc Prev. 2021 05; 28(3):251-252.
-
SARS-CoV-2/human interactome reveals ACE2 locus crosstalk with the immune regulatory network in the host. Pathog Dis. 2021 02 19; 79(2).
-
Renin-angiotensin-aldosterone inhibitors and COVID-19: nearing the end of a media-fuelled controversy. Eur J Heart Fail. 2021 03; 23(3):486-488.
-
Outcome of patients hospitalized for Covid-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: Results of the ACECoV study. Fundam Clin Pharmacol. 2021 02; 35(1):192-193.
-
Associastion of In-hospital Use of Statins, Aspirin, and Renin-Angiotensin-Aldosterone Inhibitors with Mortality and ICU Admission Due to COVID-19. Adv Exp Med Biol. 2021; 1327:205-214.
-
Does the CCR5-?32 mutation explain the variable coronavirus-2019 pandemic statistics in Europe? Croat Med J. 2020 12 31; 61(6):525-526.